Evidence is growing that common and rare genetic variants contribute to cancer risk. How will large-scale genome-wide association studies impact personalized prediction of cancer risk and prevention? Personalized Medicine
Understanding BRCA1 and BRAC2 associated risks in different populations is important in providing patients accurate risk information. Nature Reviews Cancer